secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0000950170-23-058213
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare Q3 revenue $65.3M (+14% YoY); net loss widens to $248.7M on non-cash charges
--------------------------------------------------------------------------------

- Revenue $65.3M, up 14% YoY from $57.4M; above high-end of guidance.
- Net loss $248.7M (381% of revenue) vs $6.9M loss in Q3 2022; adjusted net income $14.6M.
- Adjusted EBITDA $21.7M (33% of revenue) vs $16.4M (29%) a year ago.
- Q4 guidance: revenue $65.5M-$66.5M, adjusted EPS $0.06-$0.08 on 155.6M diluted shares.
- Enterprise customers grew 10% YoY to 555; customer win-backs and expansions noted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000095017023058213/0000950170-23-058213-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000095017023058213/dh-20231102.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-058213

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer